The Medicines Patent Pool signs licence with AbbVie to expand access to key hepatitis C treatment, glecaprevir/pibrentasvir
The licence will enable quality-assured manufacturers to develop and sell generic medicines containing G/P in low- and middle-income countries at affordable prices, enabling access to and treatment scale-up with the most effective pan-genotypic regimens.
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries.
The MPP’s patents and licences database, MedsPaL, is a resource that provides information on the intellectual property status of selected HIV, hepatitis C, tuberculosis and other patented essential medicines in low- and middle-income countries.
MPP statement at the 144th session of the WHO Executive Board on 29 January 2019, item 5.7.2:
Speaker: Esteban Burrone
The Medicines Patent Pool (MPP) welcomes the opportunity to comment on the report.
We note that the document mentions voluntary license agreements as one option to enhance affordability and accessibility.
Voluntary licences have played a strong role in facilitating access in other areas such as HIV and hepatitis C. Licences between the MPP and patent holders have enabled early entry of generic manufacturers and price competition in low- and middle-income countries (LMICs). As a result, health systems were able to procure effective new treatments at more affordable prices. Originators received a royalty. And millions of people gained access to treatments.
Last year, following strong support from WHO Member States, the MPP expanded its mandate to work on other patented essential medicines, which could include priority cancer medicines. We are currently working with the WHO and ot...
MPP statement at the 144th session of the WHO Executive Board on 29 January 2019, item 5.7.1:
Speaker: Elena Villanueva
The Medicines Patent Pool (MPP) welcomes the WHO Roadmap and the inclusion of public health-oriented licensing agreements as a way to foster access to health products.
The MPP, established by Unitaid, has become the main driver of public health-oriented licensing agreements for access to medicines in low- and middle-income countries (LMICs). It has already enabled over 100 countries to get faster access to new HIV and hepatitis C treatments at affordable prices and in suitable formulations.
We note the Roadmap proposes as a deliverable support for the expansion of the MPP to other patented essential medicines through identification of potential products for licensing. As part of this process, earlier this week, within the framework of the WHO Technical Consultation on the Essential Medicines Lists (EMLs), the MPP consulted with a number of Member States on which essential medici...
Geneva, 15 January 2019 - The Medicines Patent Pool (MPP) Governance Board has appointed Mohammed (Mo) Barry, as its newest and, at just 27-years-old, its youngest member.
Mo is a global health champion and advocate from The Gambia. He brings to this position experience of a wide-range of governance roles in the field of infectious diseases. He is a United Nations Young Ambassador for the Sustainable Development Goals; Chairperson of the HIV Young Leaders Fund; Co-Chair of UNAIDS PACT, a global youth consortium on HIV; and a One Young World Ambassador.
Prior to this, he worked for UNAIDS in Myanmar; supported policy research at the West Africa Civil Society Institute in Ghana; served on the International Treatment Preparedness Coalition World Community Advisory Board; Co-Chaired the Youth and Community Programme of the 20th International AIDS Conference in Australia and served on the board of the West Africa Treatment Action Group, monitoring access to HIV and tuberculosis treatment in 15 West African c...
“Two billion people worldwide lack access to life-changing treatments – including medicines, vaccines and diagnostic tools. Wellcome spends around £1 billion each year to support research and drive reform to improve health for people around the world. The f...”
Unable to load twitter timeline, please allow cookie